Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Danaher : Barclays Adjusts Price Target on Danaher to $300 From $265, Maintains Overweight Rating

04/26/2021 | 10:48am EDT


ę MT Newswires 2021
All news about DANAHER CORPORATION
05:06pINSIDER TRENDS : Insider 90-Day Selling Trend Prolonged at Danaher Corp
MT
07/28INSIDER TRENDS : Insider at Danaher Corp Acquires Stock Via Option/Derivative Se..
MT
07/27DANAHER : Unit, Cytiva Team Up to Invest $1.5 Billion to Expand Manufacturing Ca..
MT
07/27CYTIVA : and Pall Corporation investing 1.5 billion USD over two years to meet g..
PR
07/26DANAHER : Four Sustainability Kaizens Add Up to Savings
PU
07/26DANAHER CORP /DE/ : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/26DANAHER : Beckman Coulter to Distribute BNP Cardiac Assay to Customers
PR
07/23DANAHER : Goldman Sachs Adjusts Danaher's Price Target to $320 from $280, Keeps ..
MT
07/23DANAHER : JPMorgan Adjusts Danaher's Price Target to $310 from $280, Keeps Overw..
MT
07/23DANAHER : Wells Fargo Adjusts Danaher's Price Target to $320 from $290, Keeps Ov..
MT
More news
Financials (USD)
Sales 2021 28 653 M - -
Net income 2021 6 160 M - -
Net Debt 2021 13 539 M - -
P/E ratio 2021 35,9x
Yield 2021 0,29%
Capitalization 212 B 212 B -
EV / Sales 2021 7,87x
EV / Sales 2022 7,35x
Nbr of Employees 68 000
Free-Float 74,2%
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | MarketScreener
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 297,04 $
Average target price 313,63 $
Spread / Average Target 5,59%
EPS Revisions
Managers and Directors
Rainer M. Blair President, Chief Executive Officer & Director
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Steven M. Rales Chairman
Jose Carlos GutiÚrrez Ramos Chief Science Officer & Senior Vice President
Brian W. Ellis Senior Vice President & General Counsel
Sector and Competitors